From Google Scholar Alerts
Please note that some are abstracts requiring subscriptions or purchase of the full article, others provide a more comprehensive view of the paper.

FDG-PET/CT is superior to bone scan for detection of bone metastases from rhabdomyosarcoma at staging
J Fox, S Gavane, A Price, S Wolden, H Schoder… - Society of Nuclear Medicine …, 2014
Objectives: To compare the performance of FDG-PET/CT with bone scan (BS) for detection
of bone metastases (BM) at initial staging of rhabdomyosarcoma (RMS). Methods: RMS
patients who underwent a staging FDG-PET/CT and BS within 3 wks, and< 2 wks after ...

Additive value of 18F-FDG PET/CT in evaluation of treatment response of pediatric rhabdomyosarcoma
A Kandeel, H Elsayd - Society of Nuclear Medicine Annual Meeting Abstracts, 2014
Objectives: The aim of the current study was to clarify the role of 18F-FDG PET/CT compared
with conventional imaging in assessment of therapeutic response of pediatric
rhabdomyosarcoma (RMS) Methods: A retrospective analysis of 27 patients with ...

Starting a PET/CT service in a freestanding children’s hospital: Lessons learned
P Vyas, M Robertson, A Rice - Society of Nuclear Medicine Annual Meeting Abstracts, 2014
... The most common body diagnoses were lymphoma n= 147 (34%), rhabdomyosarcoma n= 49
(11%), Ewing's Sarcoma n= 20 (5%), neurofibromatosis n=13 (3%) and leukemia n=12 (3%).
For limited brain seizure/epilepsy n= 35 (8%) and CNS malignancy or mass workup n= 30 ...

Optimizing the interval between G-CSF therapy and FDG PET imaging
A Trout, B Turpin, S Sharp, M Gelfand - Society of Nuclear Medicine Annual Meeting …, 2014
... by stimulated marrow. Methods: FDG PET scans performed in patients with Ewing
sarcoma or rhabdomyosarcoma were retrospectively reviewed by two reviewers
blinded to G-CSF administration. Reviewers subjectively scored ...

Minimally invasive surgery in the management of abdominal tumors in children
AD Malkan, AHP Loh, JA Sandoval - Journal of Pediatric Surgery, 2014
... Laparoscopic biopsies for tumors such as abdominal neuroblastoma (NB) and
rhabdomyosarcoma and other intraabdominal tumors have resulted in adequate
tissue procurement for diagnostic analysis [9] and [11]. Although ...

Treatment options for alveolar soft part sarcoma in pediatric patients
G Bisogno, A Ferrari, R Alaggio, D Orbach - Expert Opinion on Orphan Drugs, 2014
... Pediatric oncologists usually include ASPS among the heterogeneous group of non-
rhabdomyosarcoma soft tissue sarcomas (NRSTS), where 4.5% of all cases are ASPS [6]. In
adulthood, ASPS accounts for 0.7% of all soft tissue sarcomas [7]. The course of ASPS may be ...

Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours
SA Kembhavi, V Rangarajan, S Shah, S Qureshi… - Clinical Radiology, 2014
... procedures (standard of care). Materials and methods. Eligible cases of neuroblastoma,
primitive neuroectodermal tumour, and rhabdomyosarcoma were enrolled in the study
after obtaining informed consent. WB-MRI was undertaken ...

IMMUNOGENIC PEPTIDES AND METHODS OF USE FOR TREATING AND PREVENTING CANCER
JA Berzofsky, BLT Van Den, CL Mackall, LJ Helman - US Patent 20,140,141,004, 2014
... 38. The method of claim 37, wherein the tumor cell is an alveolar rhabdomyosarcoma
cell. 39. ... 50. The method of claim 48, wherein the cancer is alveolar rhabdomyosarcoma.
Description: CROSS-REFERENCE TO RELATED APPLICATIONS. ...

Caped Crusader: Adventures in therapy with a patient who is super inspiring.
K Gardner - 2014
... Last December I got one of those rare cases. Sam is an energetic 5-year-old boy who was
diagnosed in August 2013 with rhabdomyosarcoma. RMS accounts for only about 3% of all
childhood cancers. Roughly 350 new cases are diagnosed each year in this country. ...

Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion
KR Bosse, AR Shukla, B Pawel, KR Chikwava, M Santi… - Cancer Genetics, 2014
... Interval growth of the bladder mass in the 3 weeks between initial imaging and initiation of therapy
was observed in a follow-up MRI ( Figure 2B). The patient is currently receiving multiagent
chemotherapy based upon the third Intergroup Rhabdomyosarcoma Study (IRS-III ...